M11-327 Study – Abbvie

M11-327 Study – Abbvie

A Multicentre Open-Label Study of the Long-Term Safety of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate, Posterior, or Pan-uveitis.

Trial Registry Number: No ACTRN

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment